Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
Go back to Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology| Amgen Inc (NASDAQ: AMGN) | Delayed: 429.88 -2.54 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $432.42 | 52 Week High | $176.85 | |||
| Open | $428.59 | 52 Week Low | $133.64 | |||
| Day High | $431.85 | P/E | 64.74 | |||
| Day Low | $426.00 | EPS | $6.64 | |||
| Volume | 2,354,736 | |||||
| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.36 +0.15 (4.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.21 | 52 Week High | $24.68 | |||
| Open | $3.20 | 52 Week Low | $9.10 | |||
| Day High | $3.38 | P/E | N/A | |||
| Day Low | $3.17 | EPS | $0.00 | |||
| Volume | 2,381,223 | |||||
